Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis.

Christopher Kc Lai,Grace Cy Lui,Yuchen Wei,Ka Chun Chong,Zigui Chen,Lowell Ling,Rita Wy Ng, Siaw Ss Boon,Wendy Cs Ho,Apple Cm Yeung,David Sc Hui,Paul Ks Chan

The Journal of infection（2022）

引用 1|浏览5

暂无评分

摘要

•COVID-19 patients with pneumonitis benefit from antiviral treatment.•Early remdesivir treatment accelerates the decline in SARS-CoV-2 respiratory concentration.•The significant viral load decline was observed from day 8 onwards after admission.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要